MTOR and breast carcinoma: Estrogens, particularly its predominant form E2, could inhibit mTOR activation in osteoblasts [7], and phytoestrogens calycosin and liquiritigenin also inhibited the activation of mTOR pathway in breast cancer cells and glioma cells, respectively [8, 9].